Os09g0521800 Antibody

What is Os09g0521800 and what cellular functions does it serve?

Os09g0521800 is a gene encoding an SPX domain-containing membrane protein in Oryza sativa (rice), specifically found in the Japonica subspecies. SPX domain-containing proteins are implicated in phosphate homeostasis and signaling pathways in plants . The protein is also known by alternative names including LOC_Os09g34990 and OsJ_17427/OsJ_17429, and is encoded on chromosome 9 of the rice genome . The SPX domain (named after SYG1, Pho81, and XPR1 proteins) is typically found in proteins involved in phosphate transport, sensing, and adaptation to phosphate starvation.

What is the specificity and cross-reactivity profile of the Os09g0521800 antibody?

The Os09g0521800 antibody demonstrates established reactivity with Oryza sativa subsp. japonica (Rice) . While specific cross-reactivity data for this exact antibody is limited in the provided search results, researchers should consider potential cross-reactivity with other SPX domain-containing proteins in rice, particularly those with high sequence similarity. When conducting experiments across different plant species, validation steps are essential as antibody specificity cannot be assumed without proper testing.

What validated applications exist for Os09g0521800 antibody?

The Os09g0521800 antibody has been validated for the following applications:

According to the product information, the antibody is specifically noted to "ensure identification of antigen" in these applications .

What is the recommended storage protocol for Os09g0521800 antibody?

Based on general antibody storage guidelines and specific manufacturer recommendations for similar products, the following storage protocol is advised:

• Store lyophilized antibody at -20°C upon receipt

• After reconstitution, aliquot and store at -20°C

• Avoid repeated freeze-thaw cycles which can degrade antibody quality

• For shipment, the product is typically transported at 4°C

How can I validate the specificity of Os09g0521800 antibody in my experiments?

Antibody validation is critical for experimental reproducibility. The "antibody characterization crisis" has highlighted that approximately 50% of commercial antibodies fail to meet basic standards for characterization, resulting in billions of dollars in research waste annually . For Os09g0521800 antibody, implement these validation strategies:

• Genetic validation: Generate CRISPR knockout/knockdown lines of Os09g0521800 in rice as negative controls

• Recombinant protein controls: Use purified Os09g0521800 protein as a positive control

• Orthogonal validation: Compare results with an alternative detection method like RT-PCR

• Independent antibody validation: Test multiple antibodies targeting different epitopes of Os09g0521800

• Pre-adsorption testing: Pre-incubate antibody with immunizing peptide to confirm signal elimination

As emphasized in recent literature: "While we agree with the statement that 'the responsibility for proof of specificity is with the purchaser, not the vendor', we argue herein that all stakeholders have responsibilities when it comes to addressing the antibody crisis" .

What experimental controls should be included when working with Os09g0521800 antibody?

Proper controls are essential for reliable interpretation of results:

The use of knockout lines has become increasingly important: "KO cell lines and model organisms have become much more readily available, thanks to CRISPR technologies, and the use of antibodies to confirm KO of a protein is just as useful a tool as the use of the KO lines to test for specificity of antibodies" .

How can I optimize immunohistochemistry protocols for Os09g0521800 detection in rice tissues?

While specific immunohistochemistry protocols for Os09g0521800 are not detailed in the search results, a methodological approach based on best practices for plant tissue immunohistochemistry includes:

• Tissue fixation: Fix rice tissues in 4% paraformaldehyde for 24 hours

• Antigen retrieval: Heat-induced epitope retrieval using citrate buffer (pH 6.0)

• Blocking optimization: Test 3-5% BSA, 5-10% normal serum, and commercial blocking reagents

• Antibody titration: Test dilution series (1:100 to 1:1000) to determine optimal signal-to-noise ratio

• Signal amplification: Consider tyramide signal amplification if target has low expression

• Detection system: Use fluorescent secondary antibodies for co-localization studies or DAB for permanent staining

• Counterstaining: Use DAPI for nuclei visualization in fluorescent detection

Successful IHC depends on balancing sensitivity and specificity while minimizing background. Drawing from experience with other antibodies, researchers should look for focal signal patterns in relevant tissues rather than diffuse staining, which may indicate non-specific binding .

How does the generation of Os09g0521800 antibody compare with modern antibody development approaches?

• Computational design: Advanced machine learning approaches like Generative Adversarial Networks (GANs) can now design antibodies with specific properties. "The Antibody-GAN uses modified Wasserstein-GANs for both single-chain (light or heavy chain) and paired-chain (light and heavy chain) antibody sequence generation. These GANs allow us to encode key properties of interest into our libraries for a feature-biased discovery platform" .

• Structure-guided approaches: "We set out to design proteins that drive the assembly of arbitrary antibodies into symmetric assemblies with well-defined structures. Previous design efforts have successfully built nanocages by computationally fusing or docking together protein building blocks with cyclic symmetry" .

• Validation requirements: Modern antibody development places greater emphasis on validation: "In a review article titled 'Antibody Validation' that was published in 2010, Bordeaux and co-authors discussed the importance of antibody characterization in some detail, while also stressing the need to differentiate between the lack of antibody characterization and scientific misconduct or data manipulation" .

Can Os09g0521800 antibody be used for studying plant-pathogen interactions or stress responses?

While specific studies using Os09g0521800 antibody for pathogen interaction studies aren't detailed in the search results, SPX domain-containing proteins are known to function in stress response pathways, particularly phosphate starvation. A methodological approach would include:

• Experimental design:

  • Expose rice plants to pathogens (e.g., Magnaporthe oryzae) or abiotic stresses (phosphate starvation, drought)

  • Collect tissue samples at defined time points (0, 6, 12, 24, 48 hours post-exposure)

  • Process tissues for protein extraction or fixation for immunohistochemistry

• Detection methods:

  • Western blot analysis to quantify protein expression changes

  • Immunolocalization to observe potential relocalization during stress

  • Co-immunoprecipitation to identify stress-induced protein interactions

• Data analysis:

  • Quantify expression levels relative to control proteins

  • Correlate expression with physiological parameters

  • Combine with transcriptomic data for integrated analysis

This methodological framework provides a robust approach to investigate potential roles of Os09g0521800 in stress responses.

What experimental artifacts should I be aware of when using Os09g0521800 antibody?

Several potential artifacts can complicate interpretation of results with Os09g0521800 antibody:

• Non-specific binding: Polyclonal antibodies may recognize epitopes on proteins other than the intended target

• Batch variability: Different lots of the same antibody may show variability in specificity and sensitivity

• Sample preparation effects: Protein denaturation during preparation may alter epitope recognition

• Cross-linking artifacts: Fixation methods can alter protein conformation and epitope accessibility

• Post-translational modifications: PTMs can mask epitopes or create new ones

To address these concerns, researchers should: "While these approaches are effective at multimerizing antibodies, they often require extensive engineering or multiple-step conjugation reactions for each new desired antibody oligomer. In the case of nanoparticles with flexibly linked Ig-binding domains, it is difficult to ensure full IgG occupancy on the particle surface and to prevent particle flocculation induced when multiple nanoparticles bind to dimeric IgGs" .

How can I troubleshoot weak or absent signal when using Os09g0521800 antibody?

If you experience weak or no signal when using Os09g0521800 antibody, systematically address the following:

How do I properly cite the use of Os09g0521800 antibody in publications?

Proper citation of research antibodies is essential for experimental reproducibility. For Os09g0521800 antibody, include:

• Target protein name (Os09g0521800/SPX domain-containing membrane protein)

• Host species (Rabbit)

• Clonality (Polyclonal)

• Manufacturer (e.g., CUSABIO or appropriate vendor)

• Catalog number (e.g., CSB-PA497622XA01OFG)

• Lot number (specific to your antibody batch)

• RRID (Research Resource Identifier) if available

This level of detail supports the growing movement toward antibody validation transparency: "It has been estimated that ~50% of commercial antibodies fail to meet even basic standards for characterization, and this problem is thought to result in financial losses of $0.4–1.8 billion per year in the United States alone" .

Can Os09g0521800 antibody be used in comparative studies across different rice varieties or related cereal crops?

While the antibody is specifically developed against Os09g0521800 from Oryza sativa subsp. japonica, comparative studies may be possible with appropriate validation:

• Cross-reactivity assessment: Test antibody against protein extracts from target species

• Sequence alignment: Perform in silico analysis of epitope conservation across species

• Dilution optimization: Different species may require adjusted antibody concentrations

• Positive controls: Include japonica rice samples as reference points

• Validation sequences: For each new species, perform knockout controls if possible

Similar approaches have been used for other antibodies: "PHY4057S [antibody showed reactivity with] Oryza sativa, Hordeum vulgare, Triticum aestivum, Setaria viridis, Zea mays, Panicum virgatum, Sorghum bicolor" . This suggests that antibodies against conserved plant proteins can often work across multiple species.

How can I integrate Os09g0521800 antibody-based assays with other research techniques?

This integrated approach allows researchers to place Os09g0521800 within broader cellular pathways and functional networks.

What considerations should be made when adapting Os09g0521800 antibody for high-throughput screening?

Adapting the Os09g0521800 antibody for high-throughput applications requires:

• Assay miniaturization: Optimize antibody concentration for 96 or 384-well formats

• Automation compatibility: Ensure protocols are compatible with liquid handling systems

• Signal optimization: Develop detection methods with appropriate dynamic range

• Quality control: Implement positive and negative controls on every plate

• Statistical design: Plan appropriate replicates and randomization

• Data normalization: Establish robust normalization methods to account for plate-to-plate variation

When conducting high-throughput screening, researchers must balance efficiency with rigor: "Current techniques for creating multivalent antibody-presenting formats include chaining together multiple antigen-binding fragments, pentameric immunoglobulin M (IgM) or IgM derivatives such as fragment crystallizable (Fc) domain hexamers, inorganic materials fused to multiple dimeric immunoglobulin G (IgG) antibodies, or protein oligomers or nanoparticles to which immunoglobulin (Ig) or Ig-binding domains are linked" .

How might emerging antibody technologies improve future studies of Os09g0521800?

Several emerging technologies could enhance Os09g0521800 research:

• Recombinant antibody technology: "Utilizing a large bank of structures (n=29) from panels of potent monoclonal antibodies we describe the mechanism of escape caused by the numerous mutations present in Omicron RBD, which includes most mAbs developed for prophylactic or therapeutic use" . Similar approaches could produce more specific Os09g0521800 antibodies.

• Antibody engineering: "The resulting model surpasses common in silico techniques by capturing residue diversity throughout the variable region, and is capable of generating extremely large, diverse libraries of novel antibodies that mimic somatically hypermutated human repertoire response" . These computational approaches could design antibodies with enhanced specificity.

• Nanotechnology integration: "We describe the computational design of two-component nanocages that overcome this limitation by uniting form and function. One structural component is any antibody or Fc fusion and the second is a designed Fc-binding homo-oligomer that drives nanocage assembly" . Similar approaches could enhance antibody sensitivity.

• Multiplexed detection: Development of antibody arrays or multiplexed detection systems could allow simultaneous analysis of Os09g0521800 alongside other SPX domain proteins.

What potential roles might Os09g0521800 play in sustainable agriculture research?

As an SPX domain-containing protein likely involved in phosphate homeostasis, Os09g0521800 could be significant for sustainable agriculture:

• Phosphate efficiency: Understanding Os09g0521800's role in phosphate uptake or utilization could lead to crops requiring less phosphate fertilizer

• Stress resistance: If Os09g0521800 functions in stress signaling, it could be a target for developing more resilient rice varieties

• Crop improvement: Os09g0521800 could be a genetic marker for selecting rice varieties with enhanced nutrient use efficiency

• Environmental impact: Reduced fertilizer requirements would decrease agricultural runoff and environmental damage

Methodologically, researchers could:

• Compare Os09g0521800 expression across rice varieties with different phosphate efficiency

• Analyze phenotypes of Os09g0521800 mutants under varying phosphate conditions

• Conduct field trials with genetically modified lines with altered Os09g0521800 expression